What’s New and How It Affects Screening Recommendations for Americans The updated guidelines are a reminder that we ...

Hoth Therapeutics, Inc. (NASDAQ: HOTH) ("Hoth" or the "Company"), a clinical-stage biopharmaceutical company, today announced that the U.S. Patent and Trademark Office ("USPTO") has issued a Notice of ...

Eli Lilly and Company (NYSE: LLY ) remains at the center of the biotech world thanks to Retatrutide, which has rapidly become one of the most important obesity-drug programs ever developed. The ...

The mRNA vaccines and therapeutics market is poised for robust growth, driven by expanding applications beyond COVID-19, ...

The video argues that cancer is not one disease but hundreds, which is why curing it has been so difficult. It focuses on the ...

Russia has claimed that it has come up with a new vaccine against the current Ebola virus strain. Here we compare their claim ...

After getting slapped with a surprise refuse-to-file letter signed by former CBER Director Vinay Prasad, Moderna’s flu ...

Pancreatic cancer has long been oncology’s most stubborn adversary. Fewer than 13% of patients survive five years after ...

From infections and allergies to brain diseases and autoimmune disorders, a wave of trials offers hope ...

Hanzlik's multiple sclerosis was destroying her freedom to live the life she wanted. She gave up her active nursing job for a ...

Phase 1 Data Shows a 43% Overall Response Rate at the Recommended Phase 2 Dose and Durable Responses Exceeding One Year and Ongoing, with a ...

Androgen receptor (AR) signaling plays a critical role in prostate cancer progression and remains a primary therapeutic ...